NO20045657L - Fremgangsmate ved fremstilling av fast doseringsform for desmopressin - Google Patents

Fremgangsmate ved fremstilling av fast doseringsform for desmopressin

Info

Publication number
NO20045657L
NO20045657L NO20045657A NO20045657A NO20045657L NO 20045657 L NO20045657 L NO 20045657L NO 20045657 A NO20045657 A NO 20045657A NO 20045657 A NO20045657 A NO 20045657A NO 20045657 L NO20045657 L NO 20045657L
Authority
NO
Norway
Prior art keywords
desmopressin
solid dosage
dosage form
preparation
pharmaceutically acceptable
Prior art date
Application number
NO20045657A
Other languages
English (en)
Other versions
NO20045657D0 (no
Inventor
Hans Lindner
Kristian Wannerberger
Lars-Erik Olsson
Ann Elisabeth Svensson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34560171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20045657(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20045657D0 publication Critical patent/NO20045657D0/no
Publication of NO20045657L publication Critical patent/NO20045657L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det er beskrevet en fremgangsåte for fremstilling av en fast doseringsform av desmopressin eller et farmasøytisk akseptabelt salt derav, omfattende å fremskaffe et desmopressinirmeholdende granulat som er egnet for komprimering til en farmasøytisk akseptabel tablett, så vel som faste doseringsformer, fortrirmsvis tabletter, som kan dannes ved nevnte fremgangsmåte.
NO20045657A 2003-12-29 2004-12-27 Fremgangsmate ved fremstilling av fast doseringsform for desmopressin NO20045657L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (en) 2003-12-29 2003-12-29 Method for preparing a solid dosage form of desmopressin

Publications (2)

Publication Number Publication Date
NO20045657D0 NO20045657D0 (no) 2004-12-27
NO20045657L true NO20045657L (no) 2005-06-30

Family

ID=34560171

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045657A NO20045657L (no) 2003-12-29 2004-12-27 Fremgangsmate ved fremstilling av fast doseringsform for desmopressin

Country Status (11)

Country Link
EP (1) EP1550439B1 (no)
AR (1) AR047155A1 (no)
AT (1) ATE319430T1 (no)
DE (1) DE60303872T2 (no)
DK (1) DK1550439T3 (no)
ES (1) ES2254858T3 (no)
IL (3) IL165780A0 (no)
NO (1) NO20045657L (no)
PT (1) PT1550439E (no)
SI (1) SI1550439T1 (no)
TW (1) TWI282284B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2584456C (en) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
SI2712622T1 (sl) 2008-05-21 2016-10-28 Ferring B.V. Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1677095A (en) * 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
IL160190A0 (en) * 2001-10-15 2004-07-25 Roehm Gmbh Use of copolymer to produce a galenic form containining a peptide or a protein as active agent
PT1501534E (pt) * 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas

Also Published As

Publication number Publication date
DE60303872T2 (de) 2006-10-19
IL165780A0 (en) 2006-01-15
TW200528141A (en) 2005-09-01
IL202881A0 (en) 2011-07-31
NO20045657D0 (no) 2004-12-27
ATE319430T1 (de) 2006-03-15
EP1550439B1 (en) 2006-03-08
HK1079696A1 (en) 2006-04-13
ES2254858T3 (es) 2006-06-16
AR047155A1 (es) 2006-01-11
TWI282284B (en) 2007-06-11
DK1550439T3 (da) 2006-04-03
DE60303872D1 (de) 2006-05-04
IL189107A0 (en) 2008-06-05
EP1550439A1 (en) 2005-07-06
SI1550439T1 (sl) 2006-08-31
PT1550439E (pt) 2006-06-30

Similar Documents

Publication Publication Date Title
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
ATE438383T1 (de) Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen
NO20084931L (no) Farmasoytiske sammensetninger
RU2008135718A (ru) Композиции клопидогреля бисульфата
IL158082A0 (en) Amlodipine camsylate and methods for the preparation thereof
DE60306120D1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
FI3769765T3 (fi) Natriumalkyylisulfaattia sisältävä farmaseuttinen koostumus
WO2005107721A3 (en) Pharmaceutical dosage form comprising pellets as well as its manufacturing process
RU2015117523A (ru) Комбинированный препарат, содержащий гемиглиптин и метформин, и способ его получения
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
WO2012087256A3 (en) Pharmaceutical capsule formulations
EA200602175A1 (ru) Агломерация кальцийсодержащего соединения прессованием на валках
WO2008006534A3 (en) Multiple unit tablets
WO2006082501A3 (en) Fast wet-massing method for the preparation of calcium-containing compositions
WO2009135950A3 (en) Process for preparing a tablet containing excipients
JP2009091362A5 (no)
TW200740424A (en) Taste masking dosage form
WO2010130393A3 (de) Schmelztablette, enthaltend ein vardenafil-salz
WO2004078108A3 (fr) Comprime de fenofibrate et procede de fabrication
NO20053368D0 (no) Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
EA201200727A1 (ru) Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения
WO2011151018A3 (en) Orodispersible tablets of erythritol and isomalt
WO2006012779A8 (en) Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical
AR047155A1 (es) METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application